News from GenomeDx A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 04, 2016, 08:00 ET

GenomeDx Publishes First Study Supporting Use of Decipher Test in Prostate Biopsy

GenomeDx Biosciences today announced publication of results that show Decipher Prostate Cancer Classifier, which is validated and commercially...

Jan 07, 2016, 08:00 ET

GenomeDx's Decipher® Test Validated to Predict Metastasis from Prostate Cancer Biopsies

 GenomeDx Biosciences today announced the first validation data supporting use of the Decipher® Prostate Cancer Classifier in...

Jan 07, 2016, 08:00 ET

Academic Center Collaborations through GenomeDx's Decipher GRID™ Help Drive New Understanding of Prostate Cancer Biomarkers

 In a series of five studies reporting results from analysis of over 5,000 patients presented today at the 2016 Genitourinary Cancers Symposium...

Jan 04, 2016, 08:00 ET

GenomeDx's Decipher GRID™ and Decipher® Test to be Featured in Seven Presentations at 2016 Genitourinary Cancers Symposium

 GenomeDx Biosciences today announced that seven abstracts featuring the Decipher Genomic Resource Information Database (Decipher GRID™)...

Dec 02, 2015, 16:30 ET

GenomeDx's Decipher GRID™ Evaluates New Biomarker for Prostate Cancer, Further Defines Utility of Decipher Prostate Cancer Test

 GenomeDx Biosciences today announced that data from two separate studies demonstrating the power of its Decipher Genomic Resource Information...

Dec 02, 2015, 16:30 ET

Study Supports Use of GenomeDx's Decipher Prostate Cancer Classifier in a Community Based Health Care Setting

 GenomeDx Biosciences today announced a study demonstrating how its Decipher® Prostate Cancer Classifier was used in a community...

Nov 25, 2015, 15:30 ET

GenomeDx's Decipher® Test and Decipher GRID™ to be Featured in Five Presentations at Society of Urologic Oncology

 GenomeDx Biosciences today announced that data from several of its programs will be presented at the Society of Urologic Oncology's 16th...

Oct 15, 2015, 08:00 ET

GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors

 GenomeDx Biosciences, a genomic information company, today announced that Tina Nova, Ph.D., and Craig Johnson have been appointed to its board...

Oct 14, 2015, 08:00 ET

Study of GenomeDx's Decipher® Prostate Cancer Test Selected as Best of ASTRO 2015

 GenomeDx Biosciences today announced that validation data for its Decipher® Prostate Cancer Classifier, a genomic test for prostate...

Oct 13, 2015, 08:00 ET

Cedars-Sinai to Join Decipher GRID™ through Partnership with GenomeDx

 GenomeDx Biosciences today announced that Cedars-Sinai has partnered with the company on the Decipher® Genomics Resource Information...

Sep 28, 2015, 08:00 ET

GenomeDx Biosciences Secures Financing from CRG

 GenomeDx Biosciences announced today that it has secured expansion financing from CRG, a premier healthcare investment firm, in the form of a...

Sep 03, 2015, 08:00 ET

GenomeDx Biosciences to Present at Baird 2015 Healthcare Conference

 GenomeDx Biosciences announced that it will present at the Baird 2015 Healthcare Conference on Thursday, September 10 at 3:10 p.m. ET in New...

Aug 05, 2015, 08:00 ET

GenomeDx Biosciences to Present at 2015 Wedbush PacGrow Healthcare Conference

GenomeDx Biosciences announced that it will present at the Wedbush PacGrow Healthcare Conference at 9:45 a.m. ET on Wednesday, August 12, in...

Aug 04, 2015, 08:00 ET

Decipher® Predicts Metastasis and Identifies Biomarkers Predictive of Aggressive Disease in African American Men

 GenomeDx Biosciences announced today that its commercially-available Decipher® testing platform identified, with statistical...

Jul 14, 2015, 08:00 ET

New Study Published on Cover of Urology Finds that Decipher® Prostate Cancer Classifier Reduces Conflicting Treatment Recommendations between Urologists and Radiation Oncologists

 GenomeDx Biosciences today announced that a study featured on the cover of Urology demonstrates that Decipher® Prostate Cancer Classifier...

Jun 30, 2015, 08:00 ET

GenomeDx Announces Exclusive Marketing and Distribution Agreement for the Decipher Prostate Cancer Classifier in Israel and the Palestinian Authority

 GenomeDx Biosciences today announced that the company signed an exclusive agreement with Medison Pharma Ltd., a leading marketer of innovative...

Jun 25, 2015, 08:00 ET

GenomeDx's Decipher Prostate Cancer Classifier Accurately Predicts Metastasis Ten Years after Prostate Removal in Study Published by European Urology

 GenomeDx Biosciences today announced that a study published in European Urology showed that its Decipher® Prostate Cancer Classifier...

Jun 01, 2015, 17:45 ET

GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting

GenomeDx Biosciences today announced that the robust Decipher® genomic analysis platform, successfully classified various subtypes of bladder...

May 30, 2015, 14:15 ET
May 28, 2015, 08:00 ET

Study published in European Urology demonstrates utility of Decipher GRID™ to evaluate ERG and other new markers with prognostic value in prostate cancer

 GenomeDx Biosciences today announced the publication of a multi-institutional validation study titled "Characterization of 1,577 primary...